The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus

Neurobiology of Disease

Volumn 36, Issue 1, 2009, Pages 169-180

  Kim, Gyung W ^a   Kim, Hyun Jeong ^a   Cho, Kyoung Joo ^a   Kim, Hyun Woo ^a   Cho, Yang Je ^a   Lee, Byung I ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Integrins; Matrix metalloproteinase; Pilocarpine; Status epilepticus

Indexed keywords

BETA1 INTEGRIN; GELATINASE B; INTEGRIN LINKED KINASE; PILOCARPINE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPILEPTIC STATE; EX VIVO STUDY; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES; ANTIGENS, CD29; CASPASE 3; CELL DEATH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HIPPOCAMPUS; IN SITU NICK-END LABELING; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; PHOSPHOPYRUVATE HYDRATASE; PROPIDIUM; SIGNAL TRANSDUCTION; STATISTICS AS TOPIC; STATUS EPILEPTICUS; TIME FACTORS; UP-REGULATION;

EID: 69649109317     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.008     Document Type: Article

References (68)

1. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
2. Attwell S., Roskelley C., and Dedhar S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19 (2000) 3811-3815
3. Becker A.J., Gillardon F., Blumcke I., Langendorfer D., Beck H., and Wiestler O.D. Differential regulation of apoptosis-related genes in resistant and vulnerable subfields of the rat epileptic hippocampus. Brain Res. Mol. Brain Res. 67 (1999) 172-176
4. Bi X., Chang V., Siman R., Tocco G., and Baudry M. Regional distribution and time-course of calpain activation following kainate-induced seizure activity in adult rat brain. Brain Res. 726 (1996) 98-108
5. Bouchard V., Demers M.J., Thibodeau S., Laquerre V., Fujita N., Tsuruo T., Beaulieu J.F., Gauthier R., Vezina A., Villeneuve L., and Vachon P.H. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J. Cell. Physiol. 212 (2007) 717-728
6. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev., Mol. Cell Biol. 3 (2002) 207-214
7. Cavalheiro E.A. The pilocarpine model of epilepsy. Ital. J. Neurol. Sci. 16 (1995) 33-37
8. Chen Z.L., and Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91 (1997) 917-925
9. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (2002) 2387-2392
10. Covolan L., et al. Ultrastructural identification of dentate granule cell death from pilocarpine-induced seizures. Epilepsy Res. 41 (2000) 9-21
11. Davies B., Kearns I.R., Ure J., Davies C.H., and Lathe R. Loss of hippocampal serine protease BSP1/neuropsin predisposes to global seizure activity. J. Neurosci. 21 (2001) 6993-7000
12. Deb S., and Gottschall P.E. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. 66 (1996) 1641-1647
13. Dube C., Marescaux C., and Nehlig A. A metabolic and neuropathological approach to the understanding of plastic changes that occur in the immature and adult rat brain during lithium-pilocarpine-induced epileptogenesis. Epilepsia 41 Suppl. 6 (2000) S36-S43
14. Endo A., Nagai N., Urano T., Takada Y., Hashimoto K., and Takada A. Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus. Neurosci. Res. 33 (1999) 1-8
15. Fasen K., Elger C.E., and Lie A.A. Distribution of alpha and beta integrin subunits in the adult rat hippocampus after pilocarpine-induced neuronal cell loss, axonal reorganization and reactive astrogliosis. Acta Neuropathol. (Berl.) 106 (2003) 319-322
16. Fatzer R., Gandini G., Jaggy A., Doherr M., and Vandevelde M. Necrosis of hippocampus and piriform lobe in 38 domestic cats with seizures: a retrospective study on clinical and pathologic findings. J. Vet. Intern. Med. 14 (2000) 100-104
17. Fujikawa D.G., Shinmei S.S., and Cai B. Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 41 Suppl. 6 (2000) S9-S13
18. Gall C.M., and Lynch G. Integrins, synaptic plasticity and epileptogenesis. Adv. Exp. Med. Biol. 548 (2004) 12-33
19. Gary D.S., and Mattson M.P. Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J. Neurochem. 76 (2001) 1485-1496
20. Gary D.S., Milhavet O., Camandola S., and Mattson M.P. Essential role for integrin linked kinase in Akt-mediated integrin survival signaling in hippocampal neurons. J. Neurochem. 84 (2003) 878-890
21. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J.C., Kawase M., Massengale J., and Chan P.H. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19 (1999) 1020-1028
22. Giancotti F.G., and Ruoslahti E. Integrin signaling. Science 285 (1999) 1028-1032
23. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., and Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297 (2002) 1186-1190
24. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., and Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25 (2005) 6401-6408
25. Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G., Radeva G., Filmus J., Bell J.C., and Dedhar S. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379 (1996) 91-96
26. Heo K., Cho Y.J., Cho K.J., Kim H.W., Kim H.J., Shin H.Y., Lee B.I., and Kim G.W. Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice. Neurosci. Lett. 398 (2006) 195-200
27. Herman S.T. Epilepsy after brain insult: targeting epileptogenesis. Neurology 59 (2002) S21-S26
28. Ingvar M., Morgan P.F., and Auer R.N. The nature and timing of excitotoxic neuronal necrosis in the cerebral cortex, hippocampus and thalamus due to flurothyl-induced status epilepticus. Acta Neuropathol. 75 (1988) 362-369
29. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., Le Diguardher T., Khrestchatisky M., and Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur. J. Neurosci. 18 (2003) 1507-1517
30. Kim G.W., Gasche Y., Grzeschik S., Copin J.C., Maier C.M., and Chan P.H. Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption?. J. Neurosci. 23 (2003) 8733-8742
31. Lee S.R., and Lo E.H. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 24 (2004) 720-727
32. Lee S.R., Wang X., Tsuji K., and Lo E.H. Extracellular proteolytic pathophysiology in the neurovascular unit after stroke. Neurol. Res. 26 (2004) 854-861
33. Lee B.I., Chan P.H., and Kim G.W. Metalloporphyrin-based superoxide dismutase mimic attenuates the nuclear translocation of apoptosis-inducing factor and the subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. Stroke 36 (2005) 2712-2717
34. Lee B.I., Lee D.J., Cho K.J., and Kim G.W. Early nuclear translocation of endonuclease G and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Neurosci. Lett. 386 (2005) 23-27
35. Levin J.I., Chen J.M., Du M.T., Nelson F.C., Wehr T., DiJoseph J.F., Killar L.M., Skala S., Sung A., Sharr M.A., Roth C.E., Jin G., Cowling R., Di L., Sherman M., Xu Z.B., March C.J., Mohler K.M., Black R.A., and Skotnicki J.S. The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines. Bioorg. Med. Chem. Lett. 11 (2001) 2975-2978
36. Levkau B., Kenagy R.D., Karsan A., Weitkamp B., Clowes A.W., Ross R., and Raines E.W. Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells. Cell Death Differ. 9 (2002) 1360-1367
37. Magnoni S., Baker A., George S.J., Duncan W.C., Kerr L.E., McCulloch J., and Horsburgh K. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol. Dis. 17 (2004) 188-197
38. Men S., Lee D.H., Barron J.R., Munoz D.G., et al. Selective neuronal necrosis associated with status epilepticus: MR findings. AJNR Am. J. Neuroradiol. 21 (2000) 1837-1840
39. Michaluk P., Kolodziej L., Mioduszewska B., Wilczynski G.M., Dzwonek J., Jaworski J., Gorecki D.C., Ottersen O.P., and Kaczmarek L. Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. J. Biol. Chem. 282 (2007) 16036-16041
40. Mills J., Digicaylioglu M., Legg A.T., Young C.E., Young S.S., Barr A.M., Fletcher L., O'Connor T.P., and Dedhar S. Role of integrin-linked kinase in nerve growth factor-stimulated neurite outgrowth. J. Neurosci. 23 (2003) 1638-1648
41. Oh L.Y., Larsen P.H., Krekoski C.A., Edwards D.R., Donovan F., Werb Z., and Yong V.W. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J. Neurosci. 19 (1999) 8464-8475
42. Pacheco Otalora L.F., Moffett J.R., and Garrido-Sanabria E.R. Selective vulnerability of hippocampal NAAGergic neurons in experimental temporal lobe epilepsy. Brain Res. 1144 (2007) 219-230
43. Pankov R., Cukierman E., Clark K., Matsumoto K., Hahn C., Poulin B., and Yamada K.M. Specific beta1 integrin site selectively regulates Akt/protein kinase B signaling via local activation of protein phosphatase 2A. J. Biol. Chem. 278 (2003) 18671-18681
44. Pitkanen A., and Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1 (2002) 173-181
45. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
46. Reeves T.M., Prins M.L., Zhu J., Povlishock J.T., and Phillips L.L. Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J. Neurosci. 23 (2003) 10182-10189
47. Rivera S., Ogier C., Jourquin J., Timsit S., Szklarczyk A.W., Miller K., Gearing A.J., Kaczmarek L., and Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur. J. Neurosci. 15 (2002) 19-32
48. Rosenberg G.A., Navratil M., Barone F., and Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 16 (1996) 360-366
49. Saito A., Hayashi T., Okuno S., Ferrand-Drake M., and Chan P.H. Interaction between XIAP and Smac/DIABLO in the mouse brain after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 1010-1019
50. Saito A., Hayashi T., Okuno S., Nishi T., and Chan P.H. Oxidative stress affects the integrin-linked kinase signaling pathway after transient focal cerebral ischemia. Stroke 35 (2004) 2560-2565
51. Shakibaei M., John T., Schulze-Tanzil G., Lehmann I., and Mobasheri A. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem. Pharmacol. 73 (2007) 1434-1445
52. Shibley H., and Smith B.N. Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res. 49 (2002) 109-120
53. Sifringer M., Stefovska V., Zentner I., Hansen B., Stepulak A., Knaute C., Marzahn J., and Ikonomidou C. The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol. Dis. 25 (2007) 526-535
54. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
55. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., and Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22 (2002) 920-930
56. Tagaya M., Haring H.P., Stuiver I., Wagner S., Abumiya T., Lucero J., Lee P., Copeland B.R., Seiffert D., and del Zoppo G.J. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J. Cereb. Blood Flow Metab. 21 (2001) 835-846
57. Takada Y., and Puzon W. Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. J. Biol. Chem. 268 (1993) 17597-17601
58. Tsirka S.E., Gualandris A., Amaral D.G., and Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377 (1995) 340-344
59. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., and Cavalheiro E.A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3 (1989) 154-171
60. Van den Steen P.E., Proost P., Wuyts A., Van Damme J., and Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96 (2000) 2673-2681
61. Wang H., Yu S.W., Koh D.W., Lew J., Coombs C., Bowers W., Federoff H.J., Poirier G.G., Dawson T.M., and Dawson V.L. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci. 24 (2004) 10963-10973
62. Weise J., et al. Expression time course and spatial distribution of activated caspase-3 after experimental status epilepticus: contribution of delayed neuronal cell death to seizure-induced neuronal injury. Neurobiol. Dis. 18 (2005) 582-590
63. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 (1997) 439-442
64. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., Wawrzyniak M., Malinowska M., Okulski P., Kolodziej L.R., Konopka W., Duniec K., Mioduszewska B., Nikolaev E., Walczak A., Owczarek D., Gorecki D.C., Zuschratter W., Ottersen O.P., and Kaczmarek L. Important role of matrix metalloproteinase 9 in epileptogenesis. J. Cell Biol. 180 (2008) 1021-1035
65. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev., Neurosci. 6 (2005) 931-944
66. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev., Neurosci. 2 (2001) 502-511
67. Zhang J.W., Deb S., and Gottschall P.E. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur. J. Neurosci. 10 (1998) 3358-3368
68. Zhang X., Cheng M., and Chintala S.K. Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2374-2383